Among these, osteopontin is selectively expressed in ACC tumor cells and represents a potential diagnostic marker, although with a remarkably low sensitivity, whereas negative HAS-1 expression in tumor cells characterizes a subset of ACC with a more aggressive clinical outcome. This evidence concerns the gene HAS1 and neoplasm.